Uncategorized

The most common complaints against providers were for surprise billing, while the top complaints for health plans included incorrectly calculating qualifying payment amounts.

The FDA backed Jeff Shuren, the agency’s former device leader, amid questions raised by The New York Times. Still, a spokesperson said the FDA has advised Shuren to take greater caution in managing recusal obligations.

  En los últimos años los hábitos de consumo de los españoles han cambiado radicalmente. El desarrollo tecnológico ha permitido la entrada del comercio electrónico, el cual ocupa un papel cada vez más protagonista en el mercado. A su vez, este …

Procept Biorobotics has added AI capabilities and switched to a single-use scope to support mass-market adoption.

Looking to build on the success of Chinook Therapeutics, founded by Versant in 2019 and acquired by Novartis last year, the companies on Thursday launched Borealis Biosciences with $150 million in funding to develop RNA therapeutics for kidney diseases.

Nearly 50,000 residents will see their debt forgiven. The initiative comes as other states and federal regulators have moved to lessen the burden of medical debt.

With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.

As the biotech implements a more focused strategy for its Roctavian hemophilia A gene therapy, BioMarin has recruited two seasoned pharma executives to bolster its C-suite.

With the potential passage of the BIOSECURE Act looming, WuXi Biologics reported a 24% drop in net profit in the first half of 2024.

While approved by the Medicines and Healthcare products Regulatory Agency, the Alzheimer’s drug failed to win the backing of the U.K.’s National Institute for Health and Care Excellence, which said that its benefits were “too small to justify the cost.”